Latest Shareholder Approvals News

Globe Metals & Mining has completed the first tranche of its $8.67 million placement, raising $6.96 million and converting $540,000 of convertible loans to equity, significantly reducing its debt ahead of the Kanyika Niobium Project’s Final Investment Decision.

Enegex Limited is set to acquire Famien Resources, gaining a substantial gold exploration portfolio in Côte d’Ivoire, backed by a $5 million placement and the appointment of seasoned explorer Paul Roberts as Managing Director.

Australian Oil Company Limited has announced an $800,000 capital raising through a two-tranche share placement aimed at advancing its Californian oil and gas projects and exploring new growth opportunities.

Magnum Mining & Exploration is advancing its strategic critical minerals projects with a focus on U.S. production and high-grade rare earth exploration in Brazil, backed by recent capital raising and government-aligned permitting efforts.

Alicanto Minerals has raised approximately $3 million through a share placement to fund exploration at its Falun and Sala projects in Sweden and to pursue potential acquisitions.

Highfield Resources has secured a A$10 million convertible note investment from existing strategic shareholders following the collapse of a proposed strategic transaction with China Minmetals and Yankuang Energy. The company also received renewed institutional backing from the Government of Navarra for its flagship Muga Potash Project.

ASX Limited reaffirms its FY26 expense growth guidance while detailing progress on its five-year transformation and addressing regulatory challenges. Strong FY25 financial results and a robust market pipeline underpin the company’s outlook.

Tigers Realm Coal's planned sale of its Russian subsidiaries faces ongoing delays due to regulatory hurdles and buyer demands for further price cuts, leaving the transaction in limbo and the company suspended from ASX trading.

Anatara Lifesciences reports steady progress in its anti-obesity pre-clinical studies with results expected by year-end, while preparing its GaRP gastrointestinal health data for publication amid ongoing commercial talks. The company also announces a key board appointment and a $1.2 million capital raise.

Insurance Australia Group (IAG) reported strong FY25 results and upgraded its FY26 guidance, reflecting the completed RACQ acquisition and ongoing strategic growth initiatives.

Australian Clinical Labs has announced a 12-month on-market share buy-back program targeting up to 10% of its shares, aiming to enhance shareholder returns without compromising its financial strength.

Dreadnought Resources reported a cash outflow in Q3 2025 driven by exploration spending but significantly strengthened its balance sheet with an $18 million capital raise post-quarter.